Global Cause
In this issue
-
s Sponsored
AMR is a responsibility for us all: Global collaboration is the solution
Bacteria know no borders – which is why tackling AMR requires global collaboration by pharma companies, governments, healthcare systems and communities. Pharmaceutical companies are working to stem the rise of antimicrobial resistance (AMR), but success requires a cooperative approach. Amalia Adler-Waxman, who leads Environmental, Social and Governance (ESG) at Teva, says: “As one of the...
-
Updates to the Core Elements of Hospital Antibiotic Stewardship Programs
Optimising the use of antibiotics is critical to effectively treat infections, protect patients from harm caused by unnecessary antibiotic use, and combat antibiotic resistance. Antibiotic stewardship programs can help clinicians improve clinical outcomes and minimise harm by improving the prescription of antibiotics. In 2019, Centers for Disease Control and Prevention (CDC) updated the hospital Core...
-
s Sponsored
Learning the hard way – what COVID-19 teaches us about the need for new medicines
AiCuris is acting now, building a solid pipeline of new anti-infective treatments and having launched its Pandemic and Resistance Emergency Preparedness (PREP) initiative. Until recently, most people have had no experience of diseases for which there are no medicines and that heavily impact the lives of a whole population. But since the arrival of COVID-19,...
-
International collaboration tackling the next global health crisis
A pharmacy-led global health partnerships approach can be effective for supporting antimicrobial stewardship and tackling antimicrobial resistance. Multisectoral (One-Health) and multi-country approach essential The same or similar antimicrobial medicines may be used to treat infectious diseases in humans and animals. Also, resistant bacteria arising in humans, animals or the environment may spread from one to...
-
Why drug-resistant tuberculosis poses a major risk to global health security
3 questions to Dr. Eliud Wandwalo, Head of TB at the Global Fund to Fight Aids, Tuberculosis and Malaria. What is drug-resistant tuberculosis? Drug-resistant tuberculosis (DR-TB) is a form of antimicrobial resistance that is difficult and costly to treat. It is caused by tuberculosis (TB) bacteria that are resistant to at least one of the...
-
How to stop a hidden pandemic
The UK’s global partnerships are fighting against drug resistance. Antimicrobial resistance (AMR) is happening right now across the world. The United Nations and its member countries are committed to ensuring healthy lives for all by 2030 – which is only ten years away. The Sustainable Development Goals depend on us ensuring everyone, everywhere is safe...
-
s Sponsored
Employing the power of the microbiome in the fight against AMR
To preserve the utility of antibiotics, the world needs to change its approach to treating disease. A potential way forward is by harnessing the power of the human microbiome. It’s all so depressingly predictable, says Per Falk, President of biopharma company Ferring Pharmaceuticals. Mankind has misused — and over-used — life-saving antibiotics, reducing their effectiveness...
-
The threat from antimicrobial resistance remains
Now, more than ever, we must remain united to preserve antimicrobials, particularly as COVID-19 has altered the way many people access healthcare. Antimicrobial resistance (AMR) remains a threat to health. In 2019 the World Health Organization declared AMR one of the 10 ten global health threats facing humanity. Public Health England’s latest English Surveillance Programme...
-
Pharma Invests $1B into Antibiotic Pipeline
The world is losing its most powerful tool in healthcare: antibiotics. The reason is rapidly rising antimicrobial resistance (AMR). Industry is taking steps to help tackle the crisis. AMR not only threaten lives, it undermines every aspect of modern medicine. COVID-19 has shown us the tremendous public health and economic consequences when we don’t have...
-
s Sponsored
How better diagnostics can support clinicians in infection control
Diagnostic testing has taken centre stage as the world attempts to control COVID-19, and this technology has the power to beat antimicrobial resistance as well. Public awareness of the need to accurately test for an infection has been heightened by COVID-19, and even more so as the northern hemisphere heads into respiratory virus season. For...